Navigation Links
2008 International Federation of Adipose Therapeutics and Science (IFATS) Conference Date Set
Date:7/2/2008

The Sixth Annual IFATS Meeting will be October 24-26, 2008 at the Catholic Institute in Toulouse, France. Investigators in basic and translational science and therapy will share knowledge, ideas, applications and prospective issues in an interactive and collaborative meeting from October 24-26, 2008 in downtown Toulouse, France. Visit http://www.ifats08.org for details.

Carmel, IN (PRWEB) July 2, 2008 -- The Sixth Annual IFATS meeting is set for October 24-26, 2008 in Toulouse, France.

Investigators in basic and translational science and therapy will share knowledge, ideas, applications and prospective issues in an interactive and collaborative meeting from October 24-26, 2008 in downtown Toulouse, France.

Conference Highlights

  • Characterization of the adipose stromal/stem cells.
  • Mechanisms and processes involved in the control of the adipose stromal/stem cells' fate.
  • Engineering and therapeutic applications in soft tissue reconstruction, bone formation and cardiovascular repair.

More detail on the topics can be found at http://www.IFATS08.org.

Schedule of Knowledge Sharing in Beautiful Toulouse
Welcome Reception at Mercure Toulouse Saint George    Thursday, October 23, 2008
Scientific Sessions            Friday, October 24, 2008
Gala Dinner at Fondation Bemberg          Friday, October 24, 2008
(Evening)
Scientific Sessions            Saturday, October 25, 2008
Wine Tasting Event            Saturday, October 25, 2008(Evening)            
Scientific Sessions            Sunday, October 26, 2008(Morning)
Meeting Adjourns at 12:00 PM         Sunday, October 26, 2008   

Toulouse, a beautiful historic city in southwest France, is the capital of the Midi-Pyrénées region, the largest region metropolitan France. The 2008 IFATS meeting will be held at the historic Catholic Institute, which is a short subway ride from the hotel district. Meeting attendees will have several fine hotel options to choose from, including Hotel Sofitel Toulouse Center, Hotel Crown Plaza Toulouse or the Mercure Toulouse Saint George. Each of the hotels is located close to an array of shops and restaurants. Visit www.IFATS08.org for hotel reservation forms.

Keynote Speakers Set to Present
We anticipate more than 150 researchers attending from dozens of countries around the world, joining with representatives of the more than 15 companies that are actively working in the area of adipose stem cells.

1. Dr. Gilbert Weidinger, Technical University of Dresden in Dresden, Germany
2. Prof. Max Lafontan, Institute of Molecular Medicine of Rangueil in Toulouse, France
3. Dr. Christian Dani, French National Institute for Health and Medical Research in Nice, France
4. Philippe Menasché MD, Hôpital Européen Georges Pompidou in Paris, France
5. Nadir Askenasy MD, PhD, Schneider Children's Medical Center of Israel in Petach Tikva, Israel

Biographies available at http://www.IFATS08.org.

About IFATS
IFATS is the world's only multi-disciplinary society that focuses on the use of stromal/stem cells derived from adipose tissue to regenerate and repair many tissues. This fascinating tissue now appears as one of the best and powerful sources of regenerating cells. For more information visit http://www.IFATS08.org.

###


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. QRxPharma Begins Trading on the International OTCQX
2. BioTime, Inc. and Embryome Sciences, Inc. Launch Embryome.com and the International Embryome Initiative
3. New York Resident Elected President of Lions Clubs International
4. The Second International Conference on Signs of Autism in Infants: Changing Outcomes through Early Identification and Intervention, October 11 and 12, 2008. Save the Date!
5. International Association for Dental Research presents awards and fellowships
6. International Dental Research Association meets in Toronto
7. NSF International Certifies Purity of Four Mannatech Products
8. Ukraines First Lady Kateryna Yushchenko Receives Inaugural MaxWell International Public Health Award
9. Emile Hirsch Visits the Democratic Republic of Congo With International Aid Agency Oxfam
10. Bruce Palsulich Joins Relsys International as Chief Innovation & Strategy Officer
11. Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: